DBK Pharma’s attempt at listing facing challenges

IPO WATCH- DBK Pharma’s second attempt to list on the EGX is running into roadblocks, Al Borsa reports. Sources tell the newspaper that the Egyptian Financial Supervisory Authority has not yet approved the company’s fair value assessment. Financial consultancy Fincorp was reportedly working on fair value studies for the listing.